2023 has so far been an outstanding year for DE.TEC.TOR with a lot of success and exciting news on their way.

We are very proud to announce that PTW, the global market leader for dosimetry solutions in radiation medicine, has added DE.TEC.TOR particle QA devices to their portfolio for non-exclusive distribution in several countries across the globe. 

“It is a honor and privilege to become partners of such a successful and well-established company, with a century-old history in the world of radiotherapy and a strong foothold in the dosimetry market,” says Giuseppe Pittà, CEO of DE.TEC.TOR.

“PTW aims to offer a full portfolio of advanced dosimetry solutions in all major market segments. We were looking to expand our particle therapy QA product line in order to meet increasing customer demands,” adds Bernd Allgaier, Managing Director of PTW. “With DE.TEC.TOR, we have found the right partner who shares our commitment to quality as well as the passion to making radiation safer in the field of radiotherapy.”

For more information, visit www.detector-group.com and www.ptwdosimetry.com